We actually had two TPS Position reports written up earlier this week with plans to release one of them. One of the stocks literally ran up 20% while we were finishing the report and breaking out of a long base pattern, so we didnt want...
XSPL $8.50 area Huge move in XSPL earlier this morning as high as $11.70 from $7.56 close last Friday. We have been saying to buy from 6.50-7.75 inclusive, and we also said we were accumulating quite a few shares ourselves under $7 recently. The reason is besides...
Today we are doing some quick notes and charts on all 6 positions, plus notes on buy ranges. Strategy Update: Recent IPO research work coming next! Our next 2-3 TPS Positions are going to be companies that have IPO'd within the last several weeks to 9-12 months....
Today we have Chart updates on all 6 positions and some general buy range notes, see each chart for annotations: XSPL Update: In the low end of our suggested 6.50-7.75 buy ranges. We said this stock could air pocket up and down due to thin float,...
Today we are updating developments if any on the 6 open positions, we did charts and brief technical notes on Wednesday this week: CLLS- $31- Cellectis effectively has about 480 million in cash, plus a 74% stake in CLXT. CLXT has 32 million shares outstanding now after...
We are updating 6 positions for the TPS Portfolio as we work towards our goal of 12 positions. Right now we have 1/2 position on AQMS and 5 Full Positions on CLLS, EXPI, ADAP, XON, and working on XSPL. CLLS is a strong buy at 24-28 and...
Updating all 5 positions in the TPS Portfolio 1/2 Long AQMS Full Positions on CLLS, EXPI, ADAP, AQMS New TPS Report Due: Monday or Tuesday next week. We are completing a full research report on a recent IPO that is flying under the radar for several reasons which we...
EXPI 14.20 First written up at $6.44 with a $7.25 Max buy , later $8.50 EXPI just reported their 1st quarter 2018 results with revenues exploding year over year up 188% and Agent count nearly tripling. Q1 2018 Highlights $62 million in revenue, 188% increase year-over-year Nearly tripled...
Just some quick thoughts for Monday morning on our positions. XON- $14.90, down from $19.19 highs last Thursday on the reaction to the quarterly report. We find the sell off way overdone and purchased a fair amount of shares at a 15.40 average on Friday working...
XON- $17 pre-market 5/11/18 Quarterly Conference Call Transcript (Advised reading) Intrexon reported their quarterly results last night and revenues were lighter than expected, perhaps causing the stock to drop $1.40 in pre-market today. It also dropped from a close breakout over 19 to 18.40 into the close...
indian xxnx horny desi indian cheating slime wife show boobs in webcam.
